|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $197,184,490 | $273,564,743 | $265,435,195 | $171,865,735 | $146,391,002 | $111,678,940 | $88,988,071 |
| Streptomycins & their derivs.; salts thereof | $8,090,980 | $9,277,158 | $6,489,842 | $7,016,811 | $5,064,721 | $4,164,098 | $5,136,215 |
| Tetracyclines & their derivs.; salts thereof | $106,893,506 | $83,254,617 | $82,002,341 | $158,574,859 | $96,323,761 | $118,922,159 | $131,614,507 |
| Chloramphenicol & its derivs.; salts thereof | $337,711 | $881,958 | $395,563 | $1,664,823 | $380,057 | $310,122 | $508,914 |
| Erythromycin & its derivs.; salts thereof | $377,127,242 | $140,967,099 | $75,036,032 | $115,453,319 | $168,270,719 | $88,099,312 | $141,054,983 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $702,525,874 | $612,809,473 | $639,941,195 | $818,487,975 | $498,406,197 | $683,154,297 | $772,033,485 |
| Total | $1,392,159,803 | $1,120,755,048 | $1,069,300,168 | $1,273,063,522 | $914,836,457 | $1,006,328,928 | $1,139,336,175 |
|
|
